Antioxidant excipient-mediated stabilization preserves FcγRIIIa binding and ADCC activity of rituximab抗氧化剂辅料介导的稳定化作用保留了利妥昔单抗与FcγRIIIa的结合能力及其ADCC活性BiologicalsIF1.52026-05-010PRE
Elucidating the role of 2-methyl imidazolium dihydrogen phosphate in preventing aggregation of Bevacizumab: A biophysical investigationJOURNAL OF MOLECULAR LIQUIDSIF5.22023-11-012PRE
Choline chloride:glycerol deep eutectic solvents assist in the permeation of daptomycin across Caco-2 cells mimicking intestinal bilayerJOURNAL OF MOLECULAR LIQUIDSIF5.22023-08-013PRE
Characterization of outcomes of amino acid modifications using a combinatorial approach to reveal physical and structural perturbations: A case study using trastuzumab biosimilarJOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCESIF2.82022-10-012PRE
Macromolecular cryoprotectants for the preservation of mammalian cell culture: lessons from crowding, overview and perspectivesJOURNAL OF MATERIALS CHEMISTRY BIF5.72022-01-0122PRE
Fabrication and characterization of starch-TPU based nanofibers for wound healing applicationsMATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONSIF8.12021-02-0168PREAI
pH dependent aggregation and conformation changes of rituximab using SAXS and its comparison with the standard regulatory approach of biophysical characterizationINTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULESIF8.52020-12-0112PREAI